KUKU

KU ScholarWorks

  • myKU
  • Email
  • Enroll & Pay
  • KU Directory
    • Login
    View Item 
    •   KU ScholarWorks
    • Dissertations and Theses
    • Theses
    • View Item
    •   KU ScholarWorks
    • Dissertations and Theses
    • Theses
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    The Development and Validation of a High-throughput Screening Method for Chlamydia trachomatis

    Thumbnail
    View/Open
    Restivo_ku_0099M_13384_DATA_1.pdf (2.104Mb)
    Issue Date
    2014-05-31
    Author
    Restivo, Keasha Nicole
    Publisher
    University of Kansas
    Format
    66 pages
    Type
    Thesis
    Degree Level
    M.A.
    Discipline
    Molecular Biosciences
    Rights
    This item is protected by copyright and unless otherwise specified the copyright of this thesis/dissertation is held by the author.
    Metadata
    Show full item record
    Abstract
    High-throughput screening is a scientific method that can be used to identify small compounds with activity against a number of bacteria and other organisms, as well as diseases, such as cancer, in a cost efficient manner within reasonable time frames. The absence of an effective HTS method for large-scale compound screening in Chlamydia hinders the identification of anti-chlamydial compounds that could serve as novel therapeutics, model molecules for the development of specific treatments, or molecular probes to gain insight into the basic biology of the organism. The absence of a high-throughput screening method is highly influenced by the obligate, intracellular nature of the organism, making enumeration of infection a time consuming and labor-intensive task, traditionally performed using an immunofluorescence assay. Recently in our laboratory, a new method for enumerating chlamydial infection was developed using a cell viability indicator, resazurin, to measure the reducing capability of the infected, eukaryotic host cells. In this study, the resazurin-based microplate assay was adapted to a high-throughput screening format and validated by screening the Prestwick Chemical library, containing many known anti-bacterial compounds, including anti-chlamydial compounds. An orthogonal assay was performed to further confirm the novel hits identified in the screen of the Prestwick Chemical library and to begin to identify the mechanisms of inhibition exuded on Chlamydia by those compounds. This high-throughput screening method was further adapted to automated liquid handling, including, plating and infecting the eukaryotic host cells, and the assay quality and reproducibility were verified by the HTS Facility at The University of Kansas in Lawrence, Kansas.
    URI
    http://hdl.handle.net/1808/14591
    Collections
    • Molecular Biosciences Dissertations and Theses [270]
    • Theses [3906]

    Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.


    We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.


    Contact KU ScholarWorks
    785-864-8983
    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    785-864-8983

    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    Image Credits
     

     

    Browse

    All of KU ScholarWorksCommunities & CollectionsThis Collection

    My Account

    Login

    Statistics

    View Usage Statistics

    Contact KU ScholarWorks
    785-864-8983
    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    785-864-8983

    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    Image Credits
     

     

    The University of Kansas
      Contact KU ScholarWorks
    Lawrence, KS | Maps
     
    • Academics
    • Admission
    • Alumni
    • Athletics
    • Campuses
    • Giving
    • Jobs

    The University of Kansas prohibits discrimination on the basis of race, color, ethnicity, religion, sex, national origin, age, ancestry, disability, status as a veteran, sexual orientation, marital status, parental status, gender identity, gender expression and genetic information in the University’s programs and activities. The following person has been designated to handle inquiries regarding the non-discrimination policies: Director of the Office of Institutional Opportunity and Access, IOA@ku.edu, 1246 W. Campus Road, Room 153A, Lawrence, KS, 66045, (785)864-6414, 711 TTY.

     Contact KU
    Lawrence, KS | Maps